Everest: Everolimus For Renal Cancer Ensuing Surgical Therapy, A Phase III Study
Posted Date: May 15, 2019
- Investigator: Shuchi Gulati
- Type of Study: Drug
This study is to find out if everolimus after surgery for kidney cancer will increase the time without cancer returning. Studies suggest one way kidney cancer grows is through chemical signaling through a protein called ?mTOR?. Everolimus is a drug that stops signaling through mTOR and may therefore
Criteria:
Eligible Patients Must Have Kidney Cancer That Has Been Removed By Surgery
Keywords:
Genitourinary Cancer, Kidney Cancer, Renal Cancer, S0931
For More Information:
Uc Cancer Center
513-584-7698
kastla@ucmail.uc.edu